The Japanese pharmaceutical industry in transition: has higher research orientation resulted in higher market value?
Year of publication: |
2007
|
---|---|
Authors: | Mahlich, Jörg C. |
Published in: |
Asian business & management. - Basingstoke : Palgrave Macmillan, ISSN 1472-4782, ZDB-ID 2180894-6. - Vol. 6.2007, 1, p. 75-94
|
Subject: | Technologiepolitik | Technology policy | Tobins Q | Tobin's Q | Pharmaindustrie | Pharmaceutical industry | Japan |
-
Umemura, Maki, (2014)
-
Howells, Jeremy, (1995)
-
R&D in Japan's pharmaceutical industry : the biological revolution, gene therapy and public policy
Oberländer, Christian, (1998)
- More ...
-
The Changing Nature of Pharmaceutical R&D - Opportunities for Asia?
Mahlich, Jörg C., (2001)
-
The Determinants of Pharmaceutical R&D Expenditures: Evidence from Japan
Mahlich, Jörg C., (2006)
-
Pharmaceutical regulation in Europe and its impact on corporate R&D
Eger, Stephan, (2014)
- More ...